INS and Hypoglycemia: Similarly, the coadministration of long-acting insulin with intravenous insulin in pediatric patients decreased the duration of insulin infusion (68.5 vs. 72 hours; p = 0.0001) and reduced hypoglycemia events (12 vs. 22; p = 0.029) without increasing hypokalemia risk [13].